India Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Increasing Generic Drug Production And Rising Demand For APIs in Drug Development

Ben Wood

India Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Increasing Generic Drug Production And Rising Demand For APIs in Drug Development

The India active pharmaceutical ingredients market is estimated to be valued at US$ 19,993.2 million in 2021 and is expected to exhibit a CAGR of 8.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The India active pharmaceutical ingredients market encompasses the manufacturing and supply of pharmaceutical raw materials used in the production of drugs. The market is driven by the increasing production of generic drugs and the rising demand for APIs in drug development. With India being a major supplier of generic drugs globally, the demand for APIs has witnessed substantial growth. The domestic pharmaceutical industry in India is also expanding, leading to increased API production. The market presents numerous growth opportunities for API manufacturers, with the potential for export to other countries.

Market Dynamics:

The India active pharmaceutical ingredients market is driven by two key factors: the increasing production of generic drugs and the rising demand for APIs in drug development. Generic drugs are affordable alternatives to branded medicines and are gaining popularity due to cost-effectiveness. This is driving the production of generic drugs, which, in turn, fuels the demand for APIs. Additionally, there has been a significant increase in the number of drug development projects, both by domestic and international pharmaceutical companies in India. This has created a substantial demand for APIs for the development of new drugs and formulations. With a favorable regulatory environment and a robust healthcare infrastructure, the Indian API market is poised for rapid growth.

SWOT Analysis:

Strength: India's active pharmaceutical ingredients (API) market has a strong domestic manufacturing base, with a wide range of API production capabilities. The country benefits from a large pool of skilled and knowledgeable workforce, leading to cost-efficient production. Furthermore, the presence of numerous top domestic API manufacturers enhances the industry's strength.

Weakness: One of the weaknesses of the India API market is the increasing regulatory scrutiny and stringent quality regulations imposed by international authorities. This poses a challenge for Indian manufacturers to comply with international standards. Additionally, the dependence on imported raw materials for API production may lead to supply chain vulnerabilities.

Opportunity: The India API market has significant growth opportunities due to the rising demand for generic drugs globally. The patent expirations of several blockbuster drugs create a favorable environment for Indian API manufacturers to increase their exports. Additionally, the increasing focus on research and development activities in the pharmaceutical sector presents opportunities for the development of innovative APIs.

Threats: The India API market could face threats from increasing competition from other low-cost manufacturing countries, such as China. The Chinese API manufacturers have a cost advantage and supply chain effectiveness, which could pose a challenge to Indian manufacturers. Additionally, the volatility in raw material prices and fluctuations in currency exchange rates can impact the cost competitiveness of the Indian API market.

Key Takeaways:

The global India active pharmaceutical ingredients market is expected to witness high growth, exhibiting a CAGR of 8.3% over the forecast period of 2023-2030, driven by increasing demand for generic drugs and the presence of a strong domestic manufacturing base. In terms of regional analysis, India is the fastest-growing and dominating region in the global API market. The country's large population base, the presence of top API manufacturers, and supportive government initiatives contribute to its dominant position. Key players operating in the India API market include Teva Pharmaceutical Industries Ltd., Solara, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, and Sun Pharmaceutical Industries Limited, among others.

https://www.dailyprbulletin.com/india-active-pharmaceutical-ingredients-api-market-shaping-the-future-of-the-healthcare-industry/

Ben Wood

The Active Pharmaceutical Ingredients Market Is Estimated To Witness High Growth Owing To Opportunity In Generics Drugs Manufacturer

Poonam 2024-01-05

The global Active Pharmaceutical Ingredients Market is estimated to be valued at US$ 7. Porter's Analysis Threat of new entrants: The Active Pharmaceutical Ingredients market has moderate barriers to entry due to high capital requirements and stringent regulations. Competitive rivalry: The global Active Pharmaceutical Ingredients market is highly competitive due to presence of major international players. Key players analysis: Key players operating in the Active Pharmaceutical Ingredients market are Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. The global Active Pharmaceutical Ingredients market is highly competitive due fragmentation of industry and presence of numerous international and regional vendors.

India Active Pharmaceutical Ingredients Market Growth is Accelerated by Increasing Generic Drugs Manufacturing

Sumedha 2024-01-15

The active pharmaceutical ingredients (API) are the component of any drug that produces its effects. The rising prevalence of chronic diseases and growing geriatric population propel the demand for affordable drugs, boosting the active pharmaceutical ingredients market in India. This opportunity can propel the growth of the active pharmaceutical ingredients market in India over the forecast period. Porter's AnalysisThreat of new entrants: The threat of new entrants in the India active pharmaceutical ingredients market is moderate. Key TakeawaysThe India Active Pharmaceutical Ingredients Market Size is expected to witness high growth over the forecast period of 2023-2030 supported by a growing domestic pharmaceutical industry and rising exports.

Active Pharmaceutical Ingredients (API) Market worth $248.3 billion by 2025

Makarand Vaidya 2022-04-01

Expected Growth in Revenue Generation:The global active pharmaceutical ingredients market is projected to reach USD 248. id=263In 2019, the innovative APIs segment accounted for the largest share of the active pharmaceutical ingredients marketBased on type, the active pharmaceutical ingredients market is segmented into innovative and generic APIs. The innovative APIs segment accounted for the largest share of the global active pharmaceutical ingredients market in 2019. North America was the largest regional market for active pharmaceutical ingredients market in 2019The global active pharmaceutical ingredients market is segmented into North America, Europe, Asia, Latin America, and Rest of the World. In 2019, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia.

Global Active Pharmaceutical Ingredients (APIs) Market will be US$ 261.3 Billion by 2027

renubresearch 2023-01-24

According to Renub Research's latest report, "Global Active Pharmaceutical Ingredients (API) Market, Size, forecast 2023-2027, Industry Trends, Share, Growth, Company Analysis," the Global API (Active Pharmaceutical Ingredients) Market will reach US$ 261. Competitive Landscape:The key competitors who are dealing in active pharmaceutical ingredients (API) are; Sanofi SA, F. Synthetic - Global Active Pharmaceutical Ingredients Market breakup into two viewpoints (Biotech and Synthetic). Manufacturer Type - By manufacturer type, Global Active Pharmaceutical Ingredients Market break up into two viewpoints (Captive and Merchant). Application - Global Active Pharmaceutical Ingredients Market breaks up into six viewpoints (cardiology, oncology, CNS and neurology, orthopedic, endocrinology, and others).

Active Pharmaceutical Ingredients Market 2023 - By Size, Segmentation, Application, Outlook And Opportunities Analysis By 2032

sai tbrc 2023-09-19

The Active Pharmaceutical Ingredients Global Market Report 2023, provides comprehensive information on the active pharmaceutical ingredients market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The market size of the active pharmaceutical ingredients market is expected to grow to $275. id=8539&type=smp The active pharmaceutical ingredients market is segmented:1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)2) By Type Of Manufacturer: Captive Manufacturers, Merchant Manufacturers3) By Type Of Synthesis: Synthetic APIs (Active Pharmaceutical Ingredient), Biotech APIs (Active Pharmaceutical Ingredient)4) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs5) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications North America was the largest region in the active pharmaceutical ingredients market in 2022. Africa Active Pharmaceutical Ingredients Market27. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients Market29.

Active Pharmaceutical Ingredients: The Core of Any Medicine

Omkar Patel 2024-02-20

At the heart of any medicine lies the active pharmaceutical ingredient (API) that is responsible for the intended medical benefit. An active pharmaceutical ingredient, commonly abbreviated as API, refers to the biologically active component of any pharmaceutical drug product. Rigorous quality control checks are performed during all stages of API development and manufacturing. Key Global API Producers and Suppliers The API industry has grown immensely with several major producers worldwide. - North China Pharmaceutical Group (China): One of China's biggest producers of bulk APIs catering to both domestic and foreign pharmaceutical needs.

WHO TO FOLLOW

MORE FROM AUTHOR

Software testing and QA services market Is Estimated To Witness High Growth

Ben Wood 2023-11-08

Primary Care Physicians Market Is Estimated To Witness High Growth Owing To Increasing Healthcare Expenditure And Aging Population

Ben Wood 2023-11-08

Market Is Estimated To Witness High Growth Owing To Increased Focus On Quality Assurance and Regulatory Approval

Ben Wood 2023-11-07

Market Is Estimated To Witness High Growth Owing To Increased Administration Efficacy And Patient Compliance

Ben Wood 2023-11-07

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

India Active Pharmaceutical Ingredients Market Forecast and Oppotunity 2027

Nirbhay Kulshrestha 2023-03-21

Increasing incidence of chronic diseases is expected to drive the growth of India Active Pharmaceutical Ingredients market during the forecast period. Browse 21 Figures spread through 70 Pages and an in-depth TOC on “ India Active Pharmaceutical Ingredients Market”https://www. htmlThe India active pharmaceutical ingredients market is segmented based on method of synthesis, source, therapeutic application, drug type, company, and region. , Solara Active Pharma Sciences, GlaxoSmithKline Pharmaceuticals Ltd, and others are some of the major players operating in the India active pharmaceutical ingredients market. This is further expected to create lucrative opportunities for the market growth of India Active Pharmaceutical Ingredients market over the next five years.

Growth Prospects of the India Active Pharmaceutical Ingredients Market

Pooja salve 2023-07-07

The India Active Pharmaceutical Ingredients (API) market is experiencing promising growth prospects driven by various factors. With a strong presence in the global pharmaceutical industry, India has become a major API supplier worldwide. The rising burden of chronic diseases, a growing geriatric population, and the expansion of the generic drug market are further driving the India Active Pharmaceutical Ingredients Market demand. The India API market holds immense growth potential due to favorable market dynamics, government support, and the country's strong manufacturing capabilities. The India Active Pharmaceutical Ingredients (API) market has emerged as a thriving sector within the pharmaceutical industry.

Active Pharmaceutical Ingredients Market – The New Ways to Win in Emerging Markets Forecast to 2020-2027

Ashish Mandar 2020-11-18

The report covers an overview of the industry along with a detailed explanation that provides a lot of insight.

The report also analyzes the production as well as management technology in various end-user industries.

An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very detailed have been included in the report of the Active Pharmaceutical Ingredients market for the review period of 2020 – 2027.There are many different factors that have caused the quick expansion of the Active Pharmaceutical Ingredients market.

In addition to the above, government initiatives, as well as the competitive landscape that exists in the Active Pharmaceutical Ingredients market through the forecast period, has been analyzed.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/active-pharmaceutical-ingredients-market-2103Global Active Pharmaceutical Ingredients Market Key Companies:Teva Pharmaceuticals Ltd.SandozLonza Group-AGDSMReddy’s Lab Ltd.Boehringer Ingelheim GmbHThe base year of the study is 2020 and the forecast period stretches all the way till 2027.

This has led to the creation of a strong understanding of the market for the upcoming years.

In addition to the regional segmentation, the report carries out segmentation in order to obtain detailed as well as insightful insights into the market.

Exploring the Role of Activated Pharmaceutical Ingredients in Drug Formulation

nicovaper 2023-07-21

IntroductionIn the fast-paced world of pharmaceutical drug formulation, activated pharmaceutical ingredients (APIs) play a pivotal role. Definition and Characteristics of Activated Pharmaceutical Ingredients (APIs)APIs are the biologically active substances within a drug that produce the desired pharmacological effect. Role of APIs in Drug Delivery SystemsAPIs contribute to the development of controlled release and targeted drug delivery systems, allowing for optimized drug release profiles and site-specific targeting. Nanotechnology-based drug delivery systems have shown promise in enhancing API delivery to specific tissues or cells. ConclusionActivated pharmaceutical ingredients are the backbone of drug formulation, enabling the development of effective and safe therapeutic solutions.

Active Pharmaceutical Ingredients Market to Reach US$235 Billion by 2023, with a CAGR of 6.8%

Ben Wood 2023-10-03

Active Pharmaceutical Ingredients are the biologically active components present in pharmaceutical drugs that have therapeutic effects on the human body. With the patent expiration of several blockbuster drugs, the market for generic drugs has witnessed significant growth. This affordability has led to increased adoption of generic drugs, especially in developing countries where healthcare costs are a major concern. Segment Analysis: The active pharmaceutical ingredients (API) market can be segmented based on type, manufacturer, and therapeutic application. Key Takeaways: The global Active Pharmaceutical Ingredients Market is expected to witness high growth, exhibiting a CAGR of 6.

Active Pharmaceutical Ingredients (API) Market Volume Forecast and Value Chain Analysis 2021 to 2026

Mark Smith 2022-01-24

According to the latest report by IMARC Group, titled "Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global active pharmaceutical ingredients (API) market report reached a value of US$ 200. An active pharmaceutical ingredient (API) is an active component of a drug that plays a vital part in the formulation of pharmaceutical drugs. com/active-pharmaceutical-ingredients-market/requestsampleGlobal Active Pharmaceutical Ingredients (API) Market Trends:The global market is majorly driven by significant growth in the pharmaceutical industry. Furthermore, the rising geriatric population, which is highly susceptible to developing fatal medical conditions, is providing a thrust to market growth. Abbvie IncActive Pharmaceutical Ingredients (API) Market Segmentation:Our report has categorized the market based on region, drug type, manufacturer, synthesis and therapeutic application.

Active Pharmaceutical Ingredients Market Industry Size, Share, Trends - Forecast Analysis 2021-2025

Melisa John 2021-10-07

Active Pharmaceutical Ingredients Market to grow by $ 64.53billion|Key Drivers and Trends|TechnavioAccording to Technavio, the active pharmaceutical ingredients market size is expected to value at $ 64.53 billion during 2021-2025.

The market sizing analysis in the report reveals that the market growth will progressing at a CAGR of over 6.10%.

The report offers exclusive detailed COVID-19 impact study, which majorly highlights vendor performance and new business opportunities during and post pandemic period.View our exclusive report on the CMOS image sensors market covering market trends, vendor analysis, and growth opportunities to improve your business - Download Free Sample Report.Active Pharmaceutical Ingredients Market Trends & DriversThe active pharmaceutical ingredients market research report has a detailed analysis on the key drivers, trends, and challenges, which will help vendors in making important business decisions and modifications to cater to the changing consumer demand.

While it is essential to capitalize on key drivers such as evolving api manufacturing scenario in developing countries, it is also crucial to understand the challenges that will impede sales during the forecast period.

Identifying and addressing market growth challenges will create additional opportunities for the existing and new market players.

Know more about COVID-19 Crisis and Recovery Analysis?

Active Pharmaceutical Ingredients(API) Market 2020 Analysis, Size, Share, Strategies and Forecast to

kiran gaikwad 2020-02-25

Industry OVERVIEW OF Active Pharmaceutical Ingredients(API) MARKET 2020 TO 2026:The market intelligence report on the Global Active Pharmaceutical Ingredients(API) Market offers accurate insights into the industry relating to the leading segments, product types, applications, and the leading geographic regions studied in this report, along with the market value, capacity, production, consumption, gross revenue, market dynamics, and forecast until the year 2026.

The Global Active Pharmaceutical Ingredients(API) Market is expected to deliver a steady growth rate in the forecast duration from 2020 to 2026.

Additionally, the report also gives a historical analysis of the market to use that data to predict future growth trends.In market segmentation by manufacturers, the report covers the following companies-Pfizer, Novartis International, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical, Eli Lilly and Company, GlaxoSmithKline, Merck & Co, AbbVie, Johnson & Johnson, Bayer, Sun Pharmaceutical Industries, DSM, Hisun Pharmacy, Huahai Pharmaceutical, North China Pharmaceutical Group, Shandong Lukang Pharmaceutical, Haerbin Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Jiangsu Hengrui Medicine, Lonza Group, Aurobindo Pharma, Lupin, Biocon, OthersFurthermore, the research report projects the changes in the supply-demand dynamics, market value, market competition, leading market players, and market estimations from 2020 to 2026.

The report has been created after analyzing its essential information in the overall Global Active Pharmaceutical Ingredients(API) market 2020, the vital market aspects influencing the market growth in the coming years.

Our team of expert analysts has scrutinized the Active Pharmaceutical Ingredients(API) market report by referring to the data provided by leading companies.In market segmentation by types of Active Pharmaceutical Ingredients(API), the report covers-Synthetic APIsBiotech APIsOthersIn market segmentation by applications of the Active Pharmaceutical Ingredients(API), the report covers the following uses-OncologyDiabetesCardiovascular DiseaseCNS and Neurological DisordersEndocrinologyOtherThe following years are used in this study to estimate the size of the Active Pharmaceutical Ingredients(API) market:Historical year: 2016-2018Base year: 2019Estimated year: 2020Forecast years: 2020 to 2026Scope of the Research:The report offers an in-depth assessment of the competitive scenario, taking into consideration the market shares held by leading companies.

It also discusses the supply-demand dynamics and key participants with vital business intelligence and helps them with a research-backed forecast for the global Active Pharmaceutical Ingredients(API) market.The evaluation includes the forecast, a summary of the competitive landscape, the market shares of competitors, as well as the market trends, demands, opportunities and challenges existing in the sector, and elaborate product analysis.

Active Pharmaceutical Ingredients Market Revenue Analysis, Company Revenue Share, Global Forecast Till 2032

David 2023-09-06

Overall, the global active pharmaceutical ingredients market has been segmented in terms of therapeutic category, synthesis, contract outsourcing, application, drug, and region. In the regional context, the North America active pharmaceutical ingredients market is set to grow significantly through 2032, owing to the availability of a range of pharmaceutical companies in the region. com/toc/detail/active-pharmaceutical-ingredients-marketAbout Global Market Insights:Global Market Insights, Inc. , is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Toll Free: 1-888-689-0688USA: +1-302-846-7766Europe: +44-742-759-8484APAC: +65-3129-7718Email:sales@gminsights.

Rising consumption of The Active Pharmaceutical Ingredients the Covid-19 Pandemic Have Strengthen the Market Growth

Ankit Gupta 2021-09-01

The Global Active Pharmaceutical Ingredients Market is accounted approximate USD 180.5 billion in 2020 and it is expected to reach approximate USD 308.3 billion by 2030 with a CAGR of 5.5% during forecast period.

While pharmaceutical innovation is saving the globe, biopharma and medtech firms now have a chance to keep up the trend.Market Dynamics and Factors:The life sciences business has seen exponential development in terms of breadth and capabilities across the value chain.

The need for significant collaboration between life sciences and healthcare firms, not just on goods but also on solutions, to assist solve the demand-supply mismatch is one of the sector's main issues.

The pandemic will likely increase demand for Active Pharmaceutical Ingredients in resource management, such as vaccinations, medications, and other critical medical supplies.Furthermore, throughout the projection period, the growing elderly population, rising noncommunicable illness prevalence and rising desire for enhanced patient experience are expected to drive revenue.

Governments in both developed and emerging markets have made deliberate decisions to confront producers and demand more access to lower-cost medications.

By mode of synthesis, the market can be segmented into synthetic API and biotech API.

Active Pharmaceutical Ingredients (APIs) Market Size to Hit $215,125.4 Million by 2023 at 4.96% CAGR

Bhagyashri Bhole 2020-02-10

Global Active Pharmaceutical Ingredients Market Research Report: Information by Manufacturing Process (Captive Manufacturing and Contract Manufacturing), Type of Synthesis (Synthetic and Biotech), by API Formulation (Generic API and Branded/Innovative API), Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology and others), Molecules (Large Molecule and Small Molecule) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023The Global Active Pharmaceutical Ingredients Market Report shows market is expected to exhibit a strong 4.96% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).

According to MRFR, the global active pharmaceutical ingredients market is expected to reach a valuation of USD 215,125.4 million by 2023.Active pharmaceutical ingredients comprise the pharmaceutically active agent in any medicine, i.e.

The growing prevalence of chronic diseases such as cardiovascular diseases (CVDs) and cancer is likely to be the major driver for the global active pharmaceutical ingredients market over the forecast period.

The growing healthcare industry and biotech sector are also likely to be major drivers for the active pharmaceutical ingredients market, as drug development has emerged as a major target for players operating in these fields.

Finding effective cures for various cancers has also emerged as a major objective for players in the active pharmaceutical ingredients market over the last few years.

Generics are copies of branded drugs that can be sold at much lower prices due to the absence of a copyright.

Active Pharmaceutical Ingredients Global Market 2024 - By Demand, Growth Factors, Trends, Key Drivers Forecast To 2033

varun@tbrc 2024-01-12

Learn More On The Active Pharmaceutical Ingredients Market:https://www. The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. The increasing incidence of chronic diseases is expected to propel the growth of the active pharmaceutical ingredients market going forward. The active pharmaceutical ingredients market report table of contents includes:1. Executive SummaryActive Pharmaceutical Ingredients Market CharacteristicsActive Pharmaceutical Ingredients Market Trends And StrategiesActive Pharmaceutical Ingredients Market - Macro Economic ScenarioGlobal Active Pharmaceutical Ingredients Market Size and Growth.

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

CD Formulation 2023-08-23

The company recently unveiled its latest collection of over 90 active pharmaceutical ingredients (APIs) to the scientific community. These APIs will serve as essential components in the formulation of various drugs. Some of these APIs include: Ascorbic Acid (Vitamin C) (CAS 50-81-7), FUSIDIC ACID (CAS 6990-06-3), SODIUM FUSIDATE (CAS 751-94-0), AMIKACIN SULFATE (CAS 39831-55-5), Tinidazole (CAS 19387-91-8), Linezolid (CAS 165800-03-3), Levofloxacin acid ester (CAS 106939-34-8), Metronidazole (CAS 443-48-1), and Norfloxacin (CAS 70458-96-7). The company offers a range of cardiovascular APIs that are essential for managing heart disease, lowering cholesterol and regulating blood pressure. To name just a few: Rivaroxaban (CAS 366789-02-8), Edaravone (CAS 89-25-8), Heparin Sodium (CAS 9041-08-1), Lomerizine Dihydrochloride (CAS 101477-54-7) and Enoxaparin Sodium (CAS 679809-58-6).

Active Pharmaceutical Ingredients Market Analysis | Size, Share, Global Demand and Industry Forecast 2027

VPR 2022-04-19

Also, the interest for nonexclusive medications is anticipated to additionally set out rewarding development open doors in the active pharmaceutical ingredients market. The assembling system-based division of the active pharmaceutical ingredients market includes hostage assembling and agreement fabricating. The kind of amalgamation fragment of the active pharmaceutical ingredients market comprises of the manufactured portion and the biotech section. The particle-based division of the active pharmaceutical ingredients market contains little atoms and huge particles. The Americas provincial active pharmaceutical ingredients market is projected to hold the essential portion of the worldwide market.